Analytes/procedures in 
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
	
	
	
	
		This program assesses the laboratory’s ability to detect CD30 expression in lymphomas, which has emerged as a key therapeutic target.
	 
    
    
    Program Information
	
			- One 10‑core tissue microarray slide
 
    
    
    Shipping Schedule
	
			- 
				Shipment A: March 17
			
- 
				Shipment B: September 8